Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer

HER2-positive advanced gastric cancer patients frequently develop resistance to trastuzumab through mechanisms still poorly understood. In breast cancer, other members of the HER-family are known to be involved in trastuzumab-resistance, as is overexpression of the scaffold protein IQGAP1. In the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Arienti, Chiara, Zanoni, Michele, Pignatta, Sara, Del Rio, Alberto, Carloni, Silvia, Tebaldi, Michela, Tedaldi, Gianluca, Tesei, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951299/
https://www.ncbi.nlm.nih.gov/pubmed/26919099
http://dx.doi.org/10.18632/oncotarget.7575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951299/
https://www.ncbi.nlm.nih.gov/pubmed/26919099
http://dx.doi.org/10.18632/oncotarget.7575

Ejemplares similares